Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ReShape Lifesciences Inc ReShape Lifesciences Announces 1-for-58 Reverse Stock Split September 19, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update August 14, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update August 13, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys July 09, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update May 15, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update May 14, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update April 01, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System March 28, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX March 04, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX February 22, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX January 24, 2024 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives December 20, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX December 12, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds November 21, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan November 08, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update November 06, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering September 29, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI September 22, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System September 21, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System September 19, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device September 14, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update August 07, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update August 03, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software June 29, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting June 28, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0 June 26, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Participate in Investor and Industry Conferences in June June 14, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update May 15, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update May 11, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes April 27, 2023 From ReShape Lifesciences Inc Via GlobeNewswire Tickers RSLS Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
